Safety and Efficacy of Prolonged Use of Bivalirudin 4 Hours After ePCI (COBER Study)
NCT04120961
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
330
Enrollment
OTHER
Sponsor class
Conditions
Coronary Heart Disease
Interventions
DRUG:
prolonged continuous use of bivalirudin
DRUG:
bivalirudin use during ePCI
Sponsor
Nanjing First Hospital, Nanjing Medical University